Naturally quiescent human lymphocytes, consisting predominantly of T cells, contain mRNA(s) that can inhibit DNA synthesis when injected into either human diploid fibroblasts 
analyzed for DNA synthesis. mRNA isolated from resting T cells is able to block the cells from entering the S phase. The block is reversible and leads to a delay in DNA synthesis. The inhibitory effect is not observed if the injected mRNA is isolated from growth-activated T cells. The disappearance of the inhibition coincides with the approach of the G1/S boundary in both the donor T cells and the recipient human fibroblasts. The mRNA of resting T cells was size-fractionated and the peak inhibitory activity was recovered in a fraction o1.5 kilobases long.
The majority of cells in tissues, organs, and the blood system of the body are in a resting state. In culture, primary cells become arrested in the G1 phase of the cell cycle when the environmental conditions become suboptimal for proliferation as a result of nutrient or serum deprivation (1) or high cell density (2) .
The study of growth control of animal cells has mainly focused on the external signals inducing growth (i.e., growth factors and their receptors) and the genes induced by them. These studies have revealed an interrelationship between protooncogenes on the one hand, and cell-cycle genes, growth factors, and their receptors on the other (3) (4) (5) . Several years ago it was proposed (6) that interruption of the transit through the G1 phase is achieved by a cell-cycle regulatory gene acting in early G1. Understanding the regulation of cell proliferation will, therefore, depend on a clarification of the molecular events controlling the G1 period, particularly the events leading to G1 arrest of the cell cycle (7) . Few data have accumulated about the molecular mechanisms that govern and induce the establishment of the Go phase. However, many studies with heterodikaryons between senescent or quiescent cells on the one hand and actively replicating normal or transformed cells on the other (8) (9) (10) (11) provided evidence that the replicative potential ofcells may be recessive and that inhibition of DNA synthesis can be observed in these hybrids. DNA synthesis and cell proliferation may, therefore, be regulated by an interplay between positive (inducer) and negative (repressor) molecules produced by the cell. (12) . The inhibition of growth of epithelial and endothelial cells in culture has also been observed with the transforming growth factor type P (for a review, see ref. 13 ).
This paper reports the existence of "S entry"-delaymRNA isolated from physiologically resting human lymphocytes. (14) . The Just prior to fixation, the exact coordinates of the fluorescent cells were determined and stored on a computer disc (16) . The coverslip was then removed from the dish, washed in phosphate-buffered saline (PBS) and fixed with glutaraldehyde (2.5% in PBS) for 15 min. After fixation, the cells were washed with PBS and stained with Hoechst dye 33258
MATERIALS AND METHODS
(1 ,pg/ml in PBS) for 30 min. The coverslip was finally washed three times with PBS, dried, mounted on a glass slide, overlaid with an autoradiographic stripping film (Kodak, AR-10), and exposed for 3 days. The position of the cells does not change during this procedure. After film development, the slide is analyzed in the microscope by recalling the coordinates from the disc. Every (B-cell specific), and CD-14 (monocyte specific). For activation of the lymphocytes, the cells were grown at 2 x 106 cells per ml in RPMI medium/5% fetal calf serum containing 0.5 Ag of ionomycin per ml (Calbiochem) and 1 ng of phorbol 12-myristate 13-acetate per ml (Sigma) for the appropriate times as described (17) . DNA synthesis activity was checked after a 10-hr pulse of an aliquot of the cells with 0.1 mM BrdUrd. After 103 cells were cytospinned, the BrdUrd incorporation into nuclei was revealed with a FITC-conjugated monoclonal antibody (Becton Dickinson).
The phenotype of the activated population was further checked by flow cytometric analysis with the following monoclonal antibodies: MLR3 and CD25, which are specific for G1 T cells. After 72 hr of activation with phorbol 12-myristate 13-acetate/ionomycin, the percentages of MLR3 and CD25 positive cells were >98% and >94%, respectively (18) . A similar percentage was observed when DNA synthesis was scored at 90 hr as described above.
Isolation and Sizing of mRNA. Total RNA was purified either by Nonidet P-40 lysis in the presence of vanadyl ribonucleoside (19) or by the GTC method (20) and, in both cases, was sedimented through a CsCI cushion (5.7 M) . Poly(A)+ RNA was selected on an oligo(dT) column (type III, Collaborative Research, Waltham, MA) according to Maniatis et al. (21) or by mAP paper (Orgenics, Israel).
Because of the low amount of poly(A) + RNA obtained, it could not be sized by sucrose gradient centrifugation. Around 5 ,ug of poly(A) + per lane was thereafter electrophoresed on a 3% NuSieve agarose TAE (40 mM, Tris acetate, pH 7.0/2 mM EDTA) in a minigel. The poly(A)+ RNA was heat denatured at 68°C before loading. The run was at 4°C for 30 min at 40 V and 10 mA.
To determine the relative size, an RNA ladder was run next to the poly(A) + slot. The strip of gel containing the poly(A) + RNA was then equilibrated in 0.5 M NaCI/10 mM Tris HCI, pH 7.0/1 mM EDTA for 30 min, and blotted onto a strip of mAP paper for 12 hr (22) . Each strip was cut in 2-mm pieces and eluted in H20 by heating at 68°C. The eluted RNA fraction was then centrifuged for 15 min in the cold at 15,000 x g in a Sorvall centrifuge to remove debris and dried down to 2 ,ul in a Speedvac. The samples were then mixed with FITC-dextran (1:1). The final RNA concentration injected corresponds to roughly 0.1-0.2 mg/ml, assuming an 80% recovery over 10 fractions. RESULTS DNA Synthesis After Microhijection of FITC-Dextran: Single Cell Assay. After microinjection of FITC-dextran, the cells were incubated for 24 hr in the presence of [3H]thymidine, and the percentage inhibition of DNA synthesis in injected cells was determined as described. At FITC-dextran concentrations above 2%, a significant inhibition (10%o) was observed. In subsequent experiments, a final concentration of 0.5% FITC-dextran was therefore used. mRNA from Resting T Cells Inhibits DNA Synthesis. The mRNA from resting or activated T cells was injected into both HeLa and IMR-90 cells at a concentration of 1 mg/ml together with FITC-dextran (0.5%). The cells were then analyzed for DNA synthesis after labeling for 24 hr with [3H]thymidine. Table 1 shows that significant inhibition of DNA synthesis occurred only when mRNA isolated from resting T cells was injected. No inhibitory activity was found with the poly(A)-fraction from resting cells at 2 mg/ml or after RNase and alkaline degradation of the poly(A)+ fraction (data not shown). When mRNA isolated from activated T cells (stimulated to grow with phorbol 12-myristate 13-acetate/ionomycin for 72 hr) was injected, there was no inhibition. On the contrary, a 10%o stimulation ofDNA synthesis was seen when mRNA from activated T cells was injected into the IMR-90 target cells. As shown later (see Fig. 6 ), RNA from both resting and activated T cells was not degraded. In each experiment, 300 cells were injected. The minimum amount of total mRNA injected per cell to obtain a significant inhibitory effect is 10-11 mg (obtained as volume injected x minimum mRNA concentration = 5 x 10 -ml x 0.2 mg/ml). This corresponds to -1 x 104 mRNA copies with an average size of 2 kilobases. Assuming that 10 copies of the inhibitory mRNA are needed to obtain significant inhibition in one cell, the relative abundance of the inhibitory mRNA species is 0.1%, which corresponds to 300 copies per resting T cell (taking the total number of mRNA copies per cell to be 3 x 105). tration of0.2 mg/ml can still appreciably inhibit the entry into S phase. From this concentration, we estimated (see Fig. 2 legend) the number of mRNA copies per cell responsible for this biological effect to be =300.
Inhibition of DNA Synthesis by Resting Cell mRNA Is Reversible. HeLa cells and human fibroblasts (IMR-90) were injected with mRNA isolated from resting T cells and labeled with [3H]thymidine for different times after injection (Fig. 3) . The micrographs show representative fields of a complete experiment with HeLa cells. At 30 hr after injection, the relative inhibition of DNA synthesis is significantly lower than after 20 hr and at 40 hr the cells have recovered their DNA synthetic capacity. Thus, the inhibitory effect of the mRNA isolated from resting T cells is reversible and causes a delay in DNA synthesis.
Disappearance of the Inhibitory Effect when Approaching the G1/S Boundary in Recipient Cells. We microinjected mRNA from resting T cells into human fibroblasts (IMR-90) at various time points after their activation with fetal calf serum. Fig. 4 shows that the latest time point when inhibitory activity of the injected mRNA can be scored is 6 hr after the activation of the fibroblasts. When the mRNA is injected 12 hr after activation, a lower inhibition is observed, and at 16 hr there is no significant inhibition. Thus, the inhibitory effect, transferred by injecting resting mRNA, disappears shows that mRNA isolated up to 24 hr after stimulation is still able to inhibit DNA synthesis in injected human fibroblasts. This effect disappeared completely when mRNA was isolated 48 hr after stimulation. This time point (48 hr) corresponds to the beginning of the DNA replication phase of the activated T cells, as shown in Fig. 5B .
Only a Discrete Size Class of mRNA Mediates Inhibition. To establish that a distinct class of mRNA is responsible for the inhibitory effect, the mRNA was size-fractionated. Heat denatured mRNA was electrophoresed through a nondenaturing agarose gel and blotted onto poly(U) paper (mAP). Strips were eluted and injected into synchronized human fibroblasts. Fig. 6A shows that the RNA in the two preparations was undegraded and that they contained the same amount of mRNA of a housekeeping (glyceraldehyde-3-phosphate dehydrogenase) gene as revealed by northern analysis. Fig. 6B shows that the peak of inhibitory activity resides in fractions 7 and 8 of the resting mRNA. These fractions correspond to a size of 1.5 genic stimulation leads to the transition from the Go to the G1 state (23) , with the subsequent production of the interleukin 2 growth factor and the interleukin 2 receptor. The interaction between them probably leads to a signal allowing the cells to enter the S phase (24) . The results show that only the mRNA isolated from resting T cells is able to block DNA synthesis, in both synchronized human fibroblasts and HeLa cells, while mRNA isolated from actively growing (72 hr after mitogenic stimulation) T cells lacks this capacity. The slow decrease in growth inhibitory RNA after mitogenic stimulation may be due to remaining resting cells after induction. This is, however, unlikely since >98% of the T cells transverse the G1 phase after induction. The block in DNA synthesis is obviously not irreversible. DNA synthesis is only temporarily delayed and both types of recipient cells can recover from the inhibition.
When injecting mRNA from resting T cells at various time points after growth activation of the recipient cells, the inhibitory effect decreases gradually as the injected cells enter DNA replication. Controls with poly(A)-RNA and RNA degradation indicate that the inhibitory activity resides in mRNA. Furthermore, the inhibitory capacity of the injected mRNA is gradually lost when the donor cells are growth stimulated. The T cells, which replicate their DNA =72 hr after mitogenic stimulation, contain mRNA with significant inhibitory activity for at least 24 hr. Thereafter, the inhibitory capacity decreases and at 72 hr after stimulation no inhibition can be registered. Thus, a correlation exists between the transit through the Go-G1 phase of the recipient cells and the inhibitory capacity of the mRNA isolated from resting T cells. We obtained the highest inhibition of the recipient cells from a size class of injected mRNA -1.5 kilobases long. Growth inhibitory RNA of a similar size class has previously been observed in rat liver mRNA (25 We thank Mrs. Nelly van der Jagt-Gonzalez and Waltraud Ackermann for preparation of the manuscript.
